Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G filed Aug 7, 2026

Form type

SCHEDULE 13G

Filing date

Aug 7, 2026

Accession number

0000093751-26-000415

Filer

Avalo Therapeutics, Inc. (CIK 1534120)